CPDA-1 209 mg/70mL

CPDA-1 209 mg/70mL is an anticoagulant solution used to preserve blood components. This intravenous solution contains citrate, phosphate, dextrose, and adenine, designed for medical use. Learn more about its applications and benefits.

CPDA-1 209 mg/70mL is primarily used to prevent blood clotting during storage. This anticoagulant solution is often employed in medical settings to maintain the viability of blood components for transfusions. The solution's formulation helps extend the shelf life of stored blood, ensuring it remains usable for longer periods. Healthcare professionals may use CPDA-1 209 mg/70mL to prepare blood for various medical procedures.

When administered intravenously, CPDA-1 209 mg/70mL works by binding calcium ions, which are essential for the clotting process. This action helps keep the blood in a liquid state, preventing it from coagulating. The solution's components also provide nutrients that support the metabolic needs of blood cells during storage. Users may notice that the blood remains fluid and viable for an extended period.

CPDA-1 209 mg/70mL should be handled with care to avoid contamination. It is important to follow proper storage guidelines to maintain the solution's efficacy. Users should ensure that the solution is administered by trained healthcare professionals to minimize the risk of adverse effects. Always check the packaging for any specific instructions or warnings.

CPDA-1 209 mg/70mL may interact with certain medications or substances that affect blood clotting. It is advisable to consult with a healthcare provider before using this solution, especially if you are taking other anticoagulants or blood thinners. Additionally, the solution should not be mixed with other medications without professional guidance to avoid potential interactions.